Merlin: The neurofibromatosis 2 tumor suppressor

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1423, Issue 2, 1999, Pages

  Gusella, James F ^a   Ramesh, Vijaya ^a   MacCollin, Mia ^a   Jacoby, Lee B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; AMINO ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; EZRIN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; LEUKOSIALIN; MEMBRANE PROTEIN; MERLIN; MOESIN; RADIXIN; RECEPTOR;

AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; GENE MUTATION; HUMAN; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

EID: 0033602365     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(99)00005-0     Document Type: Review

References (49)

1. Gutmann D.H., Aylsworth A., Carey J.C., Korf B., Marks J., Pyeritz R.E., Rubenstein A., Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. J. Am. Med. Assoc. 278:1997;51-57.
2. Rouleau G.A., Seizinger B.R., Wertelecki W., Haines J.L., Superneau D.W., Martuza R.L., Gusella J.F. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am. J. Hum. Genet. 46:1990;323-328.
3. Rouleau G.A., Wertelecki W., Haines J.L., Hobbs W.J., Trofatter J.A., Seizinger B.R., Martuza R.L., Superneau D.W., Conneally P.M., Gusella J.F. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature. 329:1987;246-248.
4. Seizinger B.R., Rouleau G., Ozelius L.J., Lane A.H., St George-Hyslop P., Huson S., Gusella J.F., Martuza R.L. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science. 236:1987;317-319.
5. Rouleau G.A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B., et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 363:1993;515-521.
6. Trofatter J.A., MacCollin M.M., Rutter J.L., Murrell J.R., Duyao M.P., Parry D.M., Eldridge R., Kley N., Menon A.G., Pulaski K., et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 72:1993;791-800.
7. Chishti A.H., Kim A.C., Marfatia S.M., Lutchman M., Hanspal M., Jindal H., Liu S.C., Low P.S., Rouleau G.A., Mohandas N., Chasis J.A., Conboy J.G., Gascard P., Takakuwa Y., Huang S.C., Benz E.J. Jr., Bretscher A., Fehon R.G., Gusella J.F., Ramesh V., Solomon F., Marchesi V.T., Tsukita S., Tsukita S., Hoover K.B., et al. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 23:1998;281-282.
8. Bianchi A.B., Hara T., Ramesh V., Gao J., Klein-Szanto A.J., Morin F., Menon A.G., Trofatter J.A., Gusella J.F., Seizinger B.R., et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat. Genet. 6:1994;185-192.
9. Bianchi A.B., Mitsunaga S.I., Cheng J.Q., Klein W.M., Jhanwar S.C., Seizinger B., Kley N., Klein-Szanto A.J., Testa J.R. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl. Acad. Sci. USA. 92:1995;10854-10858.
10. Deguen B., Goutebroze L., Giovannini M., Boisson C., van der Neut R., Jaurand M.C., Thomas G. Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene. Int. J. Cancer. 77:1998;554-560.
11. Sekido Y., Pass H.I., Bader S., Mew D.J., Christman M.F., Gazdar A.F., Minna J.D. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res. 55:1995;1227-1231.
12. Bretscher A., Reczek D., Berryman M. Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J. Cell. Sci. 110:1997;3011-3018.
13. Tsukita S., Yonemura S., Tsukita S. ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem. Sci. 22:1997;53-58.
14. Vaheri A., Carpen O., Heiska L., Helander T.S., Jaaskelainen J., Majander-Nordenswan P., Sainio M., Timonen T., Turunen O. The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr. Opin. Cell. Biol. 9:1997;659-666.
15. Tsukita S., Yonemura S. ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction. Curr. Opin. Cell. Biol. 9:1997;70-75.
16. Legg J.W., Isacke C.M. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr. Biol. 8:1998;705-708.
17. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:1994;391-401.
18. Heiska L., Alfthan K., Gronholm M., Vilja P., Vaheri A., Carpen O. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 273:1998;21893-21900.
19. Serrador J.M., Nieto M., Alonso-Lebrero J.L., del Pozo M.A., Calvo J., Furthmayr H., Schwartz-Albiez R., Lozano F., Gonzalez-Amaro R., Sanchez-Mateos P., Sanchez-Madrid F. CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood. 91:1998;4632-4644.
20. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 140:1998;885-895.
21. Turunen O., Wahlstrom T., Vaheri A. Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J. Cell Biol. 126:1994;1445-1453.
22. Roy C., Martin M., Mangeat P. A dual involvement of the amino-terminal domain of ezrin in F- and G-actin binding. J. Biol. Chem. 272:1997;20088-20095.
23. Hirao M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., Takai Y., Tsukita S., Tsukita S. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:1996;37-51.
24. Takahashi K., Sasaki T., Mammoto A., Takaishi K., Kameyama T., Tsukita S., Takai Y. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272:1997;23371-23375.
25. Takahashi K., Sasaki T., Mammoto A., Hotta I., Takaishi K., Imamura H., Nakano K., Kodama A., Takai Y. Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene. 16:1998;3279-3284.
26. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., Tsukita S., Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140:1998;647-657.
27. Mackay D.J., Esch F., Furthmayr H., Hall A. Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. J. Cell Biol. 138:1997;927-938.
28. Dransfield D.T., Bradford A.J., Smith J., Martin M., Roy C., Mangeat P.H., Goldenring J.R. Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J. 16:1997;35-43.
29. Yun C.C., Lamprecht G., Forster D.V., Sidor A. NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H+ exchanger NHE3 and the cytoskeletal protein ezrin. J. Biol. Chem. 273:1998;25856-25863.
30. Yun C.H., Oh S., Zizak M., Steplock D., Tsao S., Tse C.M., Weinman E.J., Donowitz M. cAmp-mediated inhibition of the epithelial brush border Na+/H+ exchanger, Nhe3, requires an associated regulatory protein. Proc. Natl. Acad. Sci. USA. 94:1997;3010-3015.
31. Reczek D., Bretscher A. The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J. Biol. Chem. 273:1998;18452-18458.
32. Reczek D., Berryman M., Bretscher A. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell Biol. 139:1997;169-179.
33. McClatchey A.I., Saotome I., Mercer K., Crowley D., Gusella J.F., Bronson R.T., Jacks T. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 12:1998;1121-1133.
34. LaJeunesse D.R., McCartney B.M., Fehon R.G. Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J. Cell Biol. 141:1998;1589-1599.
35. Gonzalez-Agosti C., Xu L., Pinney D., Beauchamp R., Hobbs W., Gusella J., Ramesh V. The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene. 13:1996;1239-1247.
36. Shaw R.J., McClatchey A.I., Jacks T. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin. Cell. Growth Differ. 9:1998;287-296.
37. Xu L., Gonzalez-Agosti C., Beauchamp R., Pinney D., Sterner C., Ramesh V. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells. Exp. Cell. Res. 238:1998;231-240.
38. Xu H.M., Gutmann D.H. Merlin differentially associates with the microtubule and actin cytoskeleton. J. Neurosci. Res. 51:1998;403-415.
39. Huang L., Ichimaru E., Pestonjamasp K., Cui X., Nakamura H., Lo G.Y., Lin F.I., Luna E.J., Furthmayr H. Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions. Biochem. Biophys. Res. Commun. 248:1998;548-553.
40. Sherman L., Xu H.M., Geist R.T., Saporito-Irwin S., Howells N., Ponta H., Herrlich P., Gutmann D.H. Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene. 15:1997;2505-2509.
41. Takeshima H., Izawa I., Lee P.S., Safdar N., Levin V.A., Saya H. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene. 9:1994;2135-2144.
42. Scoles D.R., Huynh D.P., Morcos P.A., Coulsell E.R., Robinson N.G., Tamanoi F., Pulst S.M. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat. Genet. 18:1998;354-359.
43. Murthy A., Gonzalez-Agosti C., Cordero E., Pinney D., Candia C., Solomon F., Gusella J., Ramesh V. NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J. Biol. Chem. 273:1998;1273-1276.
44. Short D.B., Trotter K.W., Reczek D., Kreda S.M., Bretscher A., Boucher R.C., Stutts M.J., Milgram S.L. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J. Biol. Chem. 273:1998;19797-19801.
45. Hall R.A., Ostedgaard L.S., Premont R.T., Blitzer J.T., Rahman N., Welsh M.J., Lefkowitz R.J. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc. Natl. Acad. Sci. USA. 95:1998;8496-8501.
46. Hall R.A., Premont R.T., Chow C.W., Blitzer J.T., Pitcher J.A., Claing A., Stoffel R.H., Barak L.S., Shenolikar S., Weinman E.J., Grinstein S., Lefkowitz R.J. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature. 392:1998;626-630.
47. Wang S., Raab R.W., Schatz P.J., Guggino W.B., Li M. Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett. 427:1998;103-108.
48. Jacoby L.B., MacCollin M., Barone R., Ramesh V., Gusella J.F. Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer. 17:1996;45-55.
49. Jacoby L.B., MacCollin M., Louis D.N., Mohney T., Rubio M.P., Pulaski K., Trofatter J.A., Kley N., Seizinger B., Ramesh V., et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum. Mol. Genet. 3:1994;413-419.